TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/29/07 14:13 | 6/29/07 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | M.d | 34 | 12.27 | 0 | 3 | 48 | 8 | D | |||||||||||||||
6/8/07 15:36 | 6/6/07 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | M.d | 27 | 10.00 | 0 | 3 | 91 | 6 | D | |||||||||||||||
6/6/07 15:07 | 6/5/07 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | S | -69 | 34.50 | 0 | -2 | -40 | 3 | D | |||||||||||||||
5/17/06 15:27 | 5/16/06 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | P.d | 14 | 14.20 | 0 | 1 | 33 | 4 | ||||||||||||||||
5/16/06 18:14 | 5/15/06 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | P | 15 | 14.57 | 0 | 1 | 100 | 2 | ||||||||||||||||
4/26/06 15:47 | 4/24/06 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horowitz Bernard | NY | D | P | 10 | 10.24 | 0 | 1 | New | 1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |